Please Wait
Applying Filters...
menu
    • menu
    Nanoalvand-PSE
    News
    NanoAlvand's Adriax® Boosts Cancer Treatment Safety And Efficacy

    17 Apr 2025

    // PRESS RELEASE

    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    NanoAlvand VB RM

    Contact Supplier

    Website

    AIChE Annual Meeting

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india
    Menu

    NanoAlvand

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-83967.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-90057.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    NanoAlvand's Adriax® Boosts Cancer Treatment Safety And Efficacy
    NanoAlvand's Adriax® Boosts Cancer Treatment Safety And Efficacy

    17 Apr 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/201-adriax-release

    PRESS RELEASE
    17 Apr 2025
    Share Share
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/197-forbes

    PRESS RELEASE
    09 Dec 2024
    Share Share
    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects
    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/191-ifoxa-release

    PRESS RELEASE
    30 Nov 2024
    Share Share
    Introducing Vicrista® – A New Era in Pediatric Oncology
    Introducing Vicrista® – A New Era in Pediatric Oncology

    03 Nov 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/192-vicrista-release

    PRESS RELEASE
    03 Nov 2024
    Share Share
    NanoAlvand Continues to Lead: Recognized Iran's Top Exporters
    NanoAlvand Continues to Lead: Recognized Iran's Top Exporters

    22 Oct 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/190-top-exporters

    PRESS RELEASE
    22 Oct 2024
    Share Share
    Endoxyna®; A crucial medication with a novel solution formulation
    Endoxyna®; A crucial medication with a novel solution formulation

    29 Jun 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/36-endoxyna-release

    PRESS RELEASE
    29 Jun 2024
    Share Share